Physicians and Medical Centers:
Submit your organization to our stop smoking database
|
Victor L. Marchione, MD, FCCP |
BOARD CERTIFICATIONS: INTERNAL & PULMONARY MEDICINE
| Medical Director | SMOKING CONSULTATION SERVICE IQuit SMOKING PROGRAM |
| Director of Clinical Services | INSTITUTE FOR BETTER BREATHING |
| Medical Director | HEALTH INTEGRATED SERVICES Clinical Research Division |
| Medical Director | HUDSON REHABILITATION THERAPY |
| Medical Consultant | ADVANCED RESPIRATORY |
| CERTIFICATIONS | |
|
1980 |
Dottore di Medicina |
|
1984 |
Diplomat American Board of Internal Medicine |
|
1987 |
Diplomat American Board of Pulmonary Medicine |
|
1988 |
Fellow American College of Chest Physicians |
| LICENSURE | |
|
1980 |
New Jersey |
|
1983 |
New York |
| HOSPITAL AFFILIATIONS | |
|
1985 - Present |
Christ Hospital Jersey City, New Jersey |
| Meadowlands Hospital Secaucus, New Jersey | |
|
1985- 1988 |
St. Francis Hospital Jersey City, New Jersey |
|
1985 - 1997 |
Greenville Hospital Jersey City, New Jersey |
|
1998 - 2000 |
Jersey City Medical Center Jersey City, New Jersey |
| APPOINTMENTS | |
|
1987 - 1990 |
Co-Director Pulmonary Medicine Christ Hospital Jersey City, New Jersey |
|
1988 - 1991 |
Disaster Committee Christ Hospital Jersey City, New Jersey |
|
1988 - 1990 |
ICU Committee Christ Hospital Jersey City, New Jersey |
|
1990 - 1993 |
Pharmacy Committee Christ Hospital Jersey City, New Jersey |
|
1991 - 1995 |
Critical Care Committee St. Francis Hospital Jersey City, New Jersey |
|
1992 -1995 |
Credential Committee Christ Hospital Jersey City, New Jersey |
|
1993 - 1995 |
Director of Pulmonary Medicine St. Francis Hospital Jersey City, New Jersey |
|
1996 - 2000 |
Medical Director Pavonia Medical Associates Jersey City-North Bergen-Secaucus, New Jersey |
|
1998 - Present |
Director Clinical Research Jersey Integrated Health Jersey City-North Bergen-Secaucus, New Jersey |
|
EDUCATION |
|
|
1973 |
B.S., Jersey City State College, New Jersey |
|
1981 |
M.D., University of Messina, Messina, Italy |
|
TRAINING |
|
|
1980 -1981 |
Internship (PGY-1) Medicine Mountainside Hospital, Montclair, New Jersey |
|
1981 - 1983 |
Residency (PGY-2, PGY-3) Medicine St. Michael’s Hospital, Newark, New Jersey |
|
1983 - 1985 |
Fellowship (PGY-4, PGY-5) Pulmonary Medicine New York Medical College, Westchester Medical Center, Valhalla, New York |
|
LECTURES |
|
|
1994 |
Ventilator Management Christ Hospital, Jersey City, New Jersey |
|
1995 |
COPD Update St. Francis Hospital, Jersey City, New Jersey |
|
1996 |
Lung Reduction Surgery St. Francis Hospital, Jersey City, New Jersey |
|
1997 |
Antibiotics in the Critical Care Setting Greenville Hospital, Jersey City, New Jersey |
|
2001-02 |
High Frequency Chest Wall Oscillating Vest/COPD Scottsdale, Arizona; Hilton Head, South Carolina |
|
2001 |
American College of Chest Physicians National Conference-Smoking Cessation and Practice Revenues, San Francisco, California |
|
2002 |
New York State Thoracic Society-Smoking Cessation, West Point, New York |
|
MEDIA |
|
|
1997 |
ABC News and World Report-Smoking Cessation |
|
1998 |
CBS Evening News with Dan Rather-Smoking Cessation |
|
1999 |
NBC Today Show -I Quit Smoking Cessation Program |
|
2001 |
COPD Satellite Media Tour Sponsored by Novartis |
|
2001 |
Video News Release COPD/FORADIL Sponsored by Novartis |
|
CONSULTANCY |
|
|
1999 - Present |
Advanced Respiratory |
|
1999-2001 |
Transworld Health |
|
CLINICAL RESEARCH Principal Investigator |
|
|
1999 |
Zyban 40005: The Effect of Zyban (Bupropion HCL SR) vs. Placebo as an Aid to Smoking Reduction Leading to Cessation Among Smokers Unwilling and Unable to Quit Smoking. Sponsored by GlaxoWellcome. |
|
1999 |
Randomized, Double-Blind, Double-Dummy, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Oral Augmentin SR 2000/125mg Twice Daily for 7 Days Oral Clarithromycin 500mg Twice Daily for 7 Days in the Treatment of Acute Exacerbation of Chronic Bronchitis. Sponsored by Smithkline. |
|
1999 |
Open, Non-Comparative, Multicenter Study to Assess the Efficacy and Safety of Oral Augmentin SR1750-125mgTwice Daily for 7 or 14 Days for the Treatment of Bacterial Community Acquired Pneumonia in Adults. Sponsored by SmithKline (SB-2500/547) |
|
2000 |
Multi-Center, Multinational Open Clinical Study to Explore Relationships between Genotypic and Serologic Findings and Phenotypic Manifestations in a Large Cohort of Participants. Sponsored by Genomics Collaborative (99-302/99-303) |
|
2000 |
Double-Blind, Randomized, Placebo-Controlled Surveillance Study of Asthma Event Outcomes in Subjects Receiving Either Usual Pharmacotherapy of Asthma or Usual Pharmacotherapy Plus Salmeterol 42 MCG Twice Daily. Sponsored by GlaxoWellcome (SMART) |
|
2000 |
Short Term Assessment of the Effects of High Frequency Chest Wall Oscillation on the Pulmonary Function and Quality of Life of Patients with COPD. Sponsorsed by American Biosystems, Inc. |
|
2001 |
High Frequency Chest Wall Oscillation in COPD Patients in a 90 - Day Study. Sponsored by American Biosystems, Inc. |
|
2001 |
Multicenter, Double-Blind, Randomized Study to Compare The Safety and Efficacy of Levofloxacin 750mg Once Daily for Five Days vs. Levofloxacin 500mg Once Daily for 10 Days in the Treatment of Mild to Severe Community Acquired Pneumonia in Adults. Sponsored by Ortho-McNeil (CAPS 150) |
|
2001 |
Multicenter, Open-Label, Non-Comparative Study to Evaluate the Safety and Efficacy of Levofloxacin Once Daily for Five Days in the Treatment of Mild to Severe Community-Acquired Pneumonia Adults. (CAPS 171) Sponsored by Ortho-McNeill |
|
2001 |
Randomized, Blinded Trial Studying the Efficacy and Safety pg High-Dose 750 mg. Short-Course (3-5 days) Levofloxacin Therapy in Uncomplicated and Complicated Acute Bacterial Exacerbation of Chronic Bronchitis. |
|
2001 |
Prospective, Randomized, Open-Label, Multicenter Comparison of the Efficacy and Safety of Sequential Treatment with Intravenous (IV) Oral (PO) Moxifloxacin +-IV/PO Azithromycin +- IV/PO Metronidazole Followed by Cefuroxime axetil PO +-PO Azithromycin +- PO Metronidazole in Patients with Community or Nursing Home Acquired Pneumonia. |